Geneos Wealth Management’s Symbotic SYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.7K Buy
328
+200
+156% +$10.2K ﹤0.01% 1902
2026
Q1
$6.81K Hold
128
﹤0.01% 2090
2025
Q4
$7.62K Hold
128
﹤0.01% 2040
2025
Q3
$6.9K Sell
128
-76
-37% -$3.84K ﹤0.01% 2071
2025
Q2
$7.92K Sell
204
-204
-50% -$5.34K ﹤0.01% 2407
2025
Q1
$8.25K Buy
408
+280
+219% +$7.15K ﹤0.01% 2629
2024
Q4
$3.04K Buy
+128
New +$3.64K ﹤0.01% 2483

Other funds holding SYM

Geneos Wealth Management's SYM Position: Q2 2026 in Review

Geneos Wealth Management increased its Symbotic (SYM) stake by 156% in Q2 2026, buying an estimated $10.2K and bringing the position to 328 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1902.

Geneos Wealth Management first reported a position in SYM in Q4 2024 and has held it in 7 quarters since. 417 funds tracked by Wall St. Rank hold SYM as of Q2 2026.

  • Geneos Wealth Management held 328 shares of Symbotic worth $14.7K as of Q2 2026.
  • Geneos Wealth Management bought 200 Symbotic shares in Q2 2026, an estimated $10.2K.
  • Symbotic made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1902 holding.
  • Geneos Wealth Management first reported a position in Symbotic in Q4 2024 and has held it in 7 quarters since.
  • 417 funds tracked by Wall St. Rank held Symbotic as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.